In humans, heterozygous carriers of the glucocerebrosidase 1 (GBA) L444P Gaucher mutation have an increased PD risk [26,27] and GBA mutations are associated with an earlier age at onset, a faster decline, and a higher risk of developing psychosis or dementia. This evidence concerns the gene GBA1 and Parkinson disease.